 | VB8 | 表記: | 4-[(4,4-dimethylpiperidin-1-yl)methyl]-2-methylsulfanyl-~{N}-[[(3~{R})-3-oxidanyl-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]piperidin-3-yl]methyl]benzamide | 組成式: | C33 H44 N6 O2 S | SMILES: | CSc1cc(CN2CCC(C)(C)CC2)ccc1C(=O)NC[C]3(O)CCCN(C3)c4cc(NCc5ccccc5)ncn4 | InChi: | InChI=1S/C33H44N6O2S/c1-32(2)13-16-38(17-14-32)21-26-10-11-27(28(18-26)42-3)31(40)35-22-33(41)12-7-15-39(23-33)30-19-29(36-24-37-30)34-20-25-8-5-4-6-9-25/h4-6,8-11,18-19,24,41H,7,12-17,20-23H2,1-3H3,(H,35,40)(H,34,36,37)/t33-/m1/s1 | 定義日: | 2021-05-04 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 4-[(4,4-dimethylpiperidin-1-yl)methyl]-2-methylsulfanyl-~{N}-[[(3~{R})-3-oxidanyl-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]piperidin-3-yl]methyl]benzamide |
|
 | L30 | 表記: | N-(naphthalen-1-yl)pyridine-3-carboxamide | 組成式: | C16 H12 N2 O | SMILES: | O=C(Nc1cccc2ccccc21)c1cccnc1 | InChi: | InChI=1S/C16H12N2O/c19-16(13-7-4-10-17-11-13)18-15-9-3-6-12-5-1-2-8-14(12)15/h1-11H,(H,18,19) | 定義日: | 2021-10-08 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | N-(naphthalen-1-yl)pyridine-3-carboxamide |
|
 | 5ZK | 表記: | ~{N},3-dimethyl-1~{H}-pyrazolo[4,3-d]pyrimidin-7-amine | 組成式: | C7 H9 N5 | SMILES: | CNc1ncnc2c(C)n[nH]c12 | InChi: | InChI=1S/C7H9N5/c1-4-5-6(12-11-4)7(8-2)10-3-9-5/h3H,1-2H3,(H,11,12)(H,8,9,10) | 定義日: | 2021-07-21 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N},3-dimethyl-1~{H}-pyrazolo[4,3-d]pyrimidin-7-amine |
|
 | 1GF | 表記: | (~{Z})-4-[9-[(4-fluorophenyl)methoxy]-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid | 組成式: | C35 H33 F O8 | SMILES: | COc1c(CC=C(C)C)c2C(=O)c3c(Oc2cc1OCc4ccc(F)cc4)cc5OC(C)(C)C=Cc5c3OCC=CC(O)=O | InChi: | InChI=1S/C35H33FO8/c1-20(2)8-13-24-30-26(18-28(33(24)40-5)42-19-21-9-11-22(36)12-10-21)43-27-17-25-23(14-15-35(3,4)44-25)34(31(27)32(30)39)41-16-6-7-29(37)38/h6-12,14-15,17-18H,13,16,19H2,1-5H3,(H,37,38)/b7-6- | 定義日: | 2021-06-21 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | (~{Z})-4-[9-[(4-fluorophenyl)methoxy]-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid |
|
 | 1AS | 表記: | (~{E})-4-[9-[(4-fluorophenyl)methoxy]-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid | 組成式: | C35 H33 F O8 | SMILES: | COc1c(CC=C(C)C)c2C(=O)c3c(Oc2cc1OCc4ccc(F)cc4)cc5OC(C)(C)C=Cc5c3OCC=CC(O)=O | InChi: | InChI=1S/C35H33FO8/c1-20(2)8-13-24-30-26(18-28(33(24)40-5)42-19-21-9-11-22(36)12-10-21)43-27-17-25-23(14-15-35(3,4)44-25)34(31(27)32(30)39)41-16-6-7-29(37)38/h6-12,14-15,17-18H,13,16,19H2,1-5H3,(H,37,38)/b7-6+ | 定義日: | 2021-06-17 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | (~{E})-4-[9-[(4-fluorophenyl)methoxy]-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid |
|
 | 1TH | 表記: | 4-[2-[(4-fluorophenyl)methylsulfanyl]ethyl]-3-phenyl-1H-1,2,4-triazole-5-thione | 組成式: | C17 H16 F N3 S2 | SMILES: | Fc1ccc(CSCCN2C(=S)NN=C2c3ccccc3)cc1 | InChi: | InChI=1S/C17H16FN3S2/c18-15-8-6-13(7-9-15)12-23-11-10-21-16(19-20-17(21)22)14-4-2-1-3-5-14/h1-9H,10-12H2,(H,20,22) | 定義日: | 2021-06-14 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 4-[2-[(4-fluorophenyl)methylsulfanyl]ethyl]-3-phenyl-1~{H}-1,2,4-triazole-5-thione |
|
 | 7RE | 表記: | 6-methyl-3H-pyridin-2-one | 組成式: | C6 H7 N O | SMILES: | CC1=NC(=O)CC=C1 | InChi: | InChI=1S/C6H7NO/c1-5-3-2-4-6(8)7-5/h2-3H,4H2,1H3 | 別名: | 2(3H)-Pyridinone, 6-methyl- | 定義日: | 2021-08-23 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 6-methyl-3~{H}-pyridin-2-one |
|
 | 7RI | 表記: | 5-bromanyl-N-methyl-1H-indazole-3-carboxamide | 組成式: | C9 H8 Br N3 O | SMILES: | CNC(=O)c1n[nH]c2ccc(Br)cc12 | InChi: | InChI=1S/C9H8BrN3O/c1-11-9(14)8-6-4-5(10)2-3-7(6)12-13-8/h2-4H,1H3,(H,11,14)(H,12,13) | 別名: | 1H-Indazole-3-carboxamide, 5-bromo-N-methyl- | 定義日: | 2021-08-23 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 5-bromanyl-~{N}-methyl-1~{H}-indazole-3-carboxamide |
|
 | 7RN | 表記: | N-methyl-3-(5-methylthiophen-2-yl)-1H-pyrazole-5-carboxamide | 組成式: | C10 H11 N3 O S | SMILES: | CNC(=O)c1cc([nH]n1)c2sc(C)cc2 | InChi: | InChI=1S/C10H11N3OS/c1-6-3-4-9(15-6)7-5-8(13-12-7)10(14)11-2/h3-5H,1-2H3,(H,11,14)(H,12,13) | 定義日: | 2021-08-23 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N}-methyl-5-(5-methylthiophen-2-yl)-1~{H}-pyrazole-3-carboxamide |
|
 | 7RT | 表記: | N-methyl-1H-indole-4-carboxamide | 組成式: | C10 H10 N2 O | SMILES: | CNC(=O)c1cccc2[nH]ccc12 | InChi: | InChI=1S/C10H10N2O/c1-11-10(13)8-3-2-4-9-7(8)5-6-12-9/h2-6,12H,1H3,(H,11,13) | 定義日: | 2021-08-23 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N}-methyl-1~{H}-indole-4-carboxamide |
|
 | 7RX | 表記: | (R)-homoproline | 組成式: | C6 H11 N O2 | SMILES: | OC(=O)C[CH]1CCCN1 | InChi: | InChI=1S/C6H11NO2/c8-6(9)4-5-2-1-3-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m1/s1 | 別名: | 2-[(2R)-pyrrolidin-2-yl]ethanoic acid | 定義日: | 2021-08-24 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 2-[(2~{R})-pyrrolidin-2-yl]ethanoic acid |
|
 | 7SL | 表記: | 5-(furan-2-yl)-N-methyl-1H-pyrazole-3-carboxamide | 組成式: | C9 H9 N3 O2 | SMILES: | CNC(=O)c1cc([nH]n1)c2occc2 | InChi: | InChI=1S/C9H9N3O2/c1-10-9(13)7-5-6(11-12-7)8-3-2-4-14-8/h2-5H,1H3,(H,10,13)(H,11,12) | 別名: | 5-(Furan-2-yl)-N-methyl-1H-pyrazole-3-carboxamide | 定義日: | 2021-08-24 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 5-(furan-2-yl)-~{N}-methyl-1~{H}-pyrazole-3-carboxamide |
|
 | 0X8 | 表記: | (~{E})-4-[8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-9-oxidanyl-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid | 組成式: | C28 H28 O8 | SMILES: | COc1c(O)cc2Oc3cc4OC(C)(C)C=Cc4c(OCC=CC(O)=O)c3C(=O)c2c1CC=C(C)C | InChi: | InChI=1S/C28H28O8/c1-15(2)8-9-17-23-20(13-18(29)26(17)33-5)35-21-14-19-16(10-11-28(3,4)36-19)27(24(21)25(23)32)34-12-6-7-22(30)31/h6-8,10-11,13-14,29H,9,12H2,1-5H3,(H,30,31)/b7-6+ | 定義日: | 2021-06-17 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | (~{E})-4-[8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-9-oxidanyl-6-oxidanylidene-pyrano[3,2-b]xanthen-5-yl]oxybut-2-enoic acid |
|
 | H0U | 表記: | ~{N}-[5-(5-cyanothiophen-2-yl)-2-methyl-phenyl]-4-methyl-benzenesulfonamide | 組成式: | C19 H16 N2 O2 S2 | SMILES: | Cc1ccc(cc1)[S](=O)(=O)Nc2cc(ccc2C)c3sc(cc3)C#N | InChi: | InChI=1S/C19H16N2O2S2/c1-13-3-8-17(9-4-13)25(22,23)21-18-11-15(6-5-14(18)2)19-10-7-16(12-20)24-19/h3-11,21H,1-2H3 | 定義日: | 2020-10-20 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N}-[5-(5-cyanothiophen-2-yl)-2-methyl-phenyl]-4-methyl-benzenesulfonamide |
|
 | H1C | 表記: | methyl ~{N}-(5-butyl-1~{H}-benzimidazol-2-yl)carbamate | 組成式: | C13 H17 N3 O2 | SMILES: | CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1 | InChi: | InChI=1S/C13H17N3O2/c1-3-4-5-9-6-7-10-11(8-9)15-12(14-10)16-13(17)18-2/h6-8H,3-5H2,1-2H3,(H2,14,15,16,17) | 定義日: | 2020-10-20 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | methyl ~{N}-(5-butyl-1~{H}-benzimidazol-2-yl)carbamate |
|
 | H1F | 表記: | 5-phenyl-3-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrazole-2-carbothioamide | 組成式: | C19 H21 N3 O3 S | SMILES: | COc1cc(cc(OC)c1OC)[CH]2CC(=NN2C(N)=S)c3ccccc3 | InChi: | InChI=1S/C19H21N3O3S/c1-23-16-9-13(10-17(24-2)18(16)25-3)15-11-14(21-22(15)19(20)26)12-7-5-4-6-8-12/h4-10,15H,11H2,1-3H3,(H2,20,26) | 定義日: | 2020-10-20 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 5-phenyl-3-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrazole-2-carbothioamide |
|
 | H1O | 表記: | 2-(1-methylindol-4-yl)-7-(3,4,5-trimethoxyphenyl)-1~{H}-benzimidazole | 組成式: | C25 H23 N3 O3 | SMILES: | COc1cc(cc(OC)c1OC)c2cccc3nc([nH]c23)c4cccc5n(C)ccc45 | InChi: | InChI=1S/C25H23N3O3/c1-28-12-11-17-18(8-6-10-20(17)28)25-26-19-9-5-7-16(23(19)27-25)15-13-21(29-2)24(31-4)22(14-15)30-3/h5-14H,1-4H3,(H,26,27) | 定義日: | 2020-10-20 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 2-(1-methylindol-4-yl)-7-(3,4,5-trimethoxyphenyl)-1~{H}-benzimidazole |
|
 | H1U | 表記: | N-[[3-[2-[(phenylmethyl)amino]ethyl]-1H-indol-2-yl]methyl]cycloheptanamine | 組成式: | C25 H33 N3 | SMILES: | C1CCCC(CC1)NCc2[nH]c3ccccc3c2CCNCc4ccccc4 | InChi: | InChI=1S/C25H33N3/c1-2-7-13-21(12-6-1)27-19-25-23(22-14-8-9-15-24(22)28-25)16-17-26-18-20-10-4-3-5-11-20/h3-5,8-11,14-15,21,26-28H,1-2,6-7,12-13,16-19H2 | 定義日: | 2020-10-21 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N}-[[3-[2-[(phenylmethyl)amino]ethyl]-1~{H}-indol-2-yl]methyl]cycloheptanamine |
|
 | 9EI | 表記: | 5-amino-N-(naphthalen-1-yl)pyridine-3-carboxamide | 組成式: | C16 H13 N3 O | SMILES: | O=C(Nc1cccc2ccccc21)c1cncc(N)c1 | InChi: | InChI=1S/C16H13N3O/c17-13-8-12(9-18-10-13)16(20)19-15-7-3-5-11-4-1-2-6-14(11)15/h1-10H,17H2,(H,19,20) | 定義日: | 2021-10-08 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 5-amino-N-(naphthalen-1-yl)pyridine-3-carboxamide |
|
 | 6IK | 表記: | 4-[[(3S)-3-cyclopropyl-2-azaspiro[3.3]heptan-2-yl]methyl]-N-[[(3S)-3-oxidanyl-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]piperidin-3-yl]methyl]benzamide | 組成式: | C34 H42 N6 O2 | SMILES: | O[C]1(CCCN(C1)c2cc(NCc3ccccc3)ncn2)CNC(=O)c4ccc(CN5CC6(CCC6)[CH]5C7CC7)cc4 | InChi: | InChI=1S/C34H42N6O2/c41-32(28-10-8-26(9-11-28)20-40-22-33(14-4-15-33)31(40)27-12-13-27)36-21-34(42)16-5-17-39(23-34)30-18-29(37-24-38-30)35-19-25-6-2-1-3-7-25/h1-3,6-11,18,24,27,31,42H,4-5,12-17,19-23H2,(H,36,41)(H,35,37,38)/t31-,34-/m0/s1 | 定義日: | 2021-07-28 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 4-[[(3~{S})-3-cyclopropyl-2-azaspiro[3.3]heptan-2-yl]methyl]-~{N}-[[(3~{S})-3-oxidanyl-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]piperidin-3-yl]methyl]benzamide |
|
 | RM5 | 表記: | 1-[4-chloranyl-2,6-di(propan-2-yl)phenyl]-3-[4-(2-oxidanylpropan-2-yl)furan-2-yl]sulfonyl-urea | 組成式: | C20 H27 Cl N2 O5 S | SMILES: | CC(C)c1cc(Cl)cc(C(C)C)c1NC(=O)N[S](=O)(=O)c2occ(c2)C(C)(C)O | InChi: | InChI=1S/C20H27ClN2O5S/c1-11(2)15-8-14(21)9-16(12(3)4)18(15)22-19(24)23-29(26,27)17-7-13(10-28-17)20(5,6)25/h7-12,25H,1-6H3,(H2,22,23,24) | 定義日: | 2020-10-09 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 1-[4-chloranyl-2,6-di(propan-2-yl)phenyl]-3-[4-(2-oxidanylpropan-2-yl)furan-2-yl]sulfonyl-urea |
|
 | RN5 | 表記: | 4-{(2S, 4R)-1-acetyl-4-[(1-benzothiophen-6-yl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl}benzoic acid | 組成式: | C27 H24 N2 O3 S | SMILES: | C[CH]1C[CH](Nc2ccc3ccsc3c2)c4cc(ccc4N1C(C)=O)c5ccc(cc5)C(O)=O | InChi: | InChI=1S/C27H24N2O3S/c1-16-13-24(28-22-9-7-19-11-12-33-26(19)15-22)23-14-21(8-10-25(23)29(16)17(2)30)18-3-5-20(6-4-18)27(31)32/h3-12,14-16,24,28H,13H2,1-2H3,(H,31,32)/t16-,24+/m0/s1 | 別名: | 4-[(2~{S},4~{R})-4-(1-benzothiophen-6-ylamino)-1-ethanoyl-2-methyl-3,4-dihydro-2~{H}-quinolin-6-yl]benzoic acid | 定義日: | 2020-10-09 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 4-[(2~{S},4~{R})-4-(1-benzothiophen-6-ylamino)-1-ethanoyl-2-methyl-3,4-dihydro-2~{H}-quinolin-6-yl]benzoic acid |
|
 | 0AE | 表記: | (3~{R})-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]-3-[[[6-[[(3~{S})-3-propan-2-yl-2-azoniaspiro[3.3]heptan-2-yl]methyl]naphthalen-1-yl]amino]methyl]piperidin-3-ol | 組成式: | C37 H47 N6 O | SMILES: | CC(C)[CH]1[NH+](Cc2ccc3c(NC[C]4(O)CCCN(C4)c5cc(NCc6ccccc6)ncn5)cccc3c2)CC17CCC7 | InChi: | InChI=1S/C37H46N6O/c1-27(2)35-36(15-7-16-36)24-43(35)22-29-13-14-31-30(19-29)11-6-12-32(31)39-23-37(44)17-8-18-42(25-37)34-20-33(40-26-41-34)38-21-28-9-4-3-5-10-28/h3-6,9-14,19-20,26-27,35,39,44H,7-8,15-18,21-25H2,1-2H3,(H,38,40,41)/p+1/t35-,37+/m0/s1 | 定義日: | 2021-06-03 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | (3~{R})-1-[6-[(phenylmethyl)amino]pyrimidin-4-yl]-3-[[[6-[[(3~{S})-3-propan-2-yl-2-azoniaspiro[3.3]heptan-2-yl]methyl]naphthalen-1-yl]amino]methyl]piperidin-3-ol |
|
 | 0BA | 表記: | 2-oxidanyl-N-[[(3R)-3-oxidanyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methyl]-4-[[(3S)-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide | 組成式: | C29 H38 N6 O3 | SMILES: | CC(C)[CH]1N(Cc2ccc(c(O)c2)C(=O)NC[C]3(O)CCCN(C3)c4ncnc5[nH]ccc45)CC16CCC6 | InChi: | InChI=1S/C29H38N6O3/c1-19(2)24-28(8-3-9-28)16-35(24)14-20-5-6-21(23(36)13-20)27(37)31-15-29(38)10-4-12-34(17-29)26-22-7-11-30-25(22)32-18-33-26/h5-7,11,13,18-19,24,36,38H,3-4,8-10,12,14-17H2,1-2H3,(H,31,37)(H,30,32,33)/t24-,29+/m0/s1 | 定義日: | 2021-06-03 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | 2-oxidanyl-~{N}-[[(3~{R})-3-oxidanyl-1-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methyl]-4-[[(3~{S})-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide |
|
 | 0BH | 表記: | N-[[(3R)-1-[6-(1-benzothiophen-4-ylmethylamino)pyrimidin-4-yl]-3-oxidanyl-piperidin-3-yl]methyl]-2-oxidanyl-4-[[(3S)-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide | 組成式: | C36 H44 N6 O3 S | SMILES: | CC(C)[CH]1N(Cc2ccc(c(O)c2)C(=O)NC[C]3(O)CCCN(C3)c4cc(NCc5cccc6sccc56)ncn4)CC17CCC7 | InChi: | InChI=1S/C36H44N6O3S/c1-24(2)33-35(11-4-12-35)21-42(33)19-25-8-9-28(29(43)16-25)34(44)38-20-36(45)13-5-14-41(22-36)32-17-31(39-23-40-32)37-18-26-6-3-7-30-27(26)10-15-46-30/h3,6-10,15-17,23-24,33,43,45H,4-5,11-14,18-22H2,1-2H3,(H,38,44)(H,37,39,40)/t33-,36+/m0/s1 | 定義日: | 2021-06-03 | 最終更新日: | 2021-10-15 | 公開日: | 2021-10-20 | 識別子(ID): | ~{N}-[[(3~{R})-1-[6-(1-benzothiophen-4-ylmethylamino)pyrimidin-4-yl]-3-oxidanyl-piperidin-3-yl]methyl]-2-oxidanyl-4-[[(3~{S})-3-propan-2-yl-2-azaspiro[3.3]heptan-2-yl]methyl]benzamide |
|